Harmony Biosciences Holdings Inc

+0.07 (+0.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.62B
Current PEN/A
Forward PE 34.99
2yr Forward PE 8.86
See more stats
Estimates Current Quarter
Revenue$57.1 Million
Adjusted EPS-$0.03
See more estimates
10-Day MA$29.73
50-Day MA$33.85
200-Day MAN/A
See more pivots

Harmony Biosciences Holdings, Inc. Stock, NASDAQ:HRMY

630 West Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania 19462
United States of America
Phone: +1.484.539.9800
Number of Employees:


Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded on July 25, 2017 and is headquartered in Plymouth Meeting, PA.